Spotlight
Video

Could BRAF be a new target in NSCLC?

cancergrace has 804 videos Subscribe Here

Loading........
Description: http://cancerGRACE.org/...

Drs. Nate Pennell, Mary Pinder, and Jack West discuss an encouraging study of dabrafenib, a BRAF inhibitor, for the limited number of NSCLC patients with a BRAF V600E mutation.

GRACEcastUC 142 Lung
Shared By : cancergrace
Posted on : 07/01/13
Added : 4 years ago
Category : General